Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Tuberculosis (Edinb) ; 116: 44-55, 2019 05.
Article in English | MEDLINE | ID: mdl-31153518

ABSTRACT

Low molecular weight (LMW) thiols are molecules with a functional sulfhydryl group that enable them to detoxify reactive oxygen species, reactive nitrogen species and other free radicals. Their roles range from their ability to modulate the immune system to their ability to prevent damage of biological molecules such as DNA and proteins by protecting against oxidative, nitrosative and acidic stress. LMW thiols are synthesized and found in both eukaryotes and prokaryotes. Due to their beneficial role to both eukaryotes and prokaryotes, their specific functions need to be elucidated, most especially in pathogenic prokaryotes such as Mycobacterium tuberculosis (M.tb), in order to provide a rationale for targeting their biosynthesis for drug development. Ergothioneine (ERG), mycothiol (MSH) and gamma-glutamylcysteine (GGC) are LMW thiols that have been shown to interplay to protect M.tb against cellular stress. Though ERG, MSH and GGC seem to have overlapping functions, studies are gradually revealing their unique physiological roles. Understanding their unique physiological role during the course of tuberculosis (TB) infection, would pave the way for the development of drugs that target their biosynthetic pathway. This review identifies the knowledge gap in the unique physiological roles of LMW thiols and proposes their mechanistic roles based on previous studies. In addition, it gives an update on identified inhibitors of their biosynthetic enzymes.


Subject(s)
Mycobacterium tuberculosis/metabolism , Sulfhydryl Compounds/metabolism , Tuberculosis/microbiology , Animals , Antitubercular Agents/therapeutic use , Cysteine/metabolism , Dipeptides/metabolism , Enzyme Inhibitors/therapeutic use , Enzymes/metabolism , Ergothioneine/metabolism , Glycopeptides/metabolism , Humans , Inositol/metabolism , Molecular Targeted Therapy , Molecular Weight , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/pathogenicity , Tuberculosis/drug therapy
2.
Sci Data ; 5: 180184, 2018 09 25.
Article in English | MEDLINE | ID: mdl-30251996

ABSTRACT

Mycothiol (MSH) and ergothioneine (ERG) are thiols able to compensate for each other to protect mycobacteria against oxidative stress. Gamma-glutamylcysteine (GGC), another thiol and an intermediate in ERG biosynthesis has detoxification abilities. Five enzymes are involved in ERG biosynthesis, namely EgtA, EgtB, EgtC, EgtD and EgtE. The role of these enzymes in the production of ERG had been unclear. On the other hand, the enzyme MshA is known to be essential for MSH biosynthesis. In this manuscript, we describe the raw data of the generation and characterization of Mycobacterium tuberculosis (M.tb) mutants harbouring a deletion of the gene coding for each of these enzymes, and the raw data of the phenotypic characterization of the obtained thiol-deficient M.tb mutants. High throughput screening (HTS) of off-patent drugs and natural compounds revealed few compounds that displayed a higher activity against the thiol-deficient mutants relative to the wild-type strain. The mode of action of these drugs was further investigated. Raw data displaying these results are described here.


Subject(s)
Cysteine/deficiency , Cysteine/genetics , Dipeptides/deficiency , Dipeptides/genetics , Ergothioneine/deficiency , Ergothioneine/genetics , Glycopeptides/deficiency , Glycopeptides/genetics , Inositol/deficiency , Inositol/genetics , Mycobacterium tuberculosis , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Mutation , Mycobacterium tuberculosis/chemistry , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/isolation & purification , Oxidative Stress/genetics , Sulfhydryl Compounds
3.
J Biomed Sci ; 25(1): 55, 2018 Jul 12.
Article in English | MEDLINE | ID: mdl-30001196

ABSTRACT

BACKGROUND: Three low molecular weight thiols are synthesized by Mycobacterium tuberculosis (M.tb), namely ergothioneine (ERG), mycothiol (MSH) and gamma-glutamylcysteine (GGC). They are able to counteract reactive oxygen species (ROS) and/or reactive nitrogen species (RNS). In addition, the production of ERG is elevated in the MSH-deficient M.tb mutant, while the production of MSH is elevated in the ERG-deficient mutants. Furthermore, the production of GGC is elevated in the MSH-deficient mutant and the ERG-deficient mutants. The propensity of one thiol to be elevated in the absence of the other prompted further investigations into their interplay in M.tb. METHODS: To achieve that, we generated two M.tb mutants that are unable to produce ERG nor MSH but are able to produce a moderate (ΔegtD-mshA) or significantly high (ΔegtB-mshA) amount of GGC relative to the wild-type strain. In addition, we generated an M.tb mutant that is unable to produce GGC nor MSH but is able to produce a significantly low level of ERG (ΔegtA-mshA) relative to the wild-type strain. The susceptibilities of these mutants to various in vitro and ex vivo stress conditions were investigated and compared. RESULTS: The ΔegtA-mshA mutant was the most susceptible to cellular stress relative to its parent single mutant strains (ΔegtA and ∆mshA) and the other double mutants. In addition, it displayed a growth-defect in vitro, in mouse and human macrophages suggesting; that the complete inhibition of ERG, MSH and GGC biosynthesis is deleterious for the growth of M.tb. CONCLUSIONS: This study indicates that ERG, MSH and GGC are able to compensate for each other to maximize the protection and ensure the fitness of M.tb. This study therefore suggests that the most effective strategy to target thiol biosynthesis for anti-tuberculosis drug development would be the simultaneous inhibition of the biosynthesis of ERG, MSH and GGC.


Subject(s)
Cysteine/biosynthesis , Dipeptides/biosynthesis , Ergothioneine/biosynthesis , Glycopeptides/biosynthesis , Inositol/biosynthesis , Tuberculosis/microbiology , Animals , Cysteine/antagonists & inhibitors , Cysteine/genetics , Dipeptides/antagonists & inhibitors , Dipeptides/genetics , Ergothioneine/antagonists & inhibitors , Ergothioneine/genetics , Glycopeptides/antagonists & inhibitors , Glycopeptides/genetics , Humans , Inositol/antagonists & inhibitors , Inositol/genetics , Mice , Molecular Weight , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/pathogenicity , Oxidative Stress , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Sulfhydryl Compounds/chemistry , Sulfhydryl Compounds/metabolism , Tuberculosis/drug therapy , Tuberculosis/genetics , Tuberculosis/pathology
4.
Article in English | MEDLINE | ID: mdl-29437626

ABSTRACT

The high acquisition rate of drug resistance by Mycobacterium tuberculosis necessitates the ongoing search for new drugs to be incorporated in the tuberculosis (TB) regimen. Compounds used for the treatment of other diseases have the potential to be repurposed for the treatment of TB. In this study, a high-throughput screening of compounds against thiol-deficient Mycobacterium smegmatis strains and subsequent validation with thiol-deficient M. tuberculosis strains revealed that ΔegtA and ΔmshA mutants had increased susceptibility to azaguanine (Aza) and sulfaguanidine (Su); ΔegtB and ΔegtE mutants had increased susceptibility to bacitracin (Ba); and ΔegtA, ΔmshA, and ΔegtB mutants had increased susceptibility to fusaric acid (Fu). Further analyses revealed that some of these compounds were able to modulate the levels of thiols and oxidative stress in M. tuberculosis This study reports the activities of Aza, Su, Fu, and Ba against M. tuberculosis and provides a rationale for further investigations.


Subject(s)
Antitubercular Agents/pharmacology , Mycobacterium tuberculosis/drug effects , Azaguanine/pharmacology , Mutation/genetics , Mycobacterium tuberculosis/genetics , Oxidative Stress/drug effects , Oxidative Stress/genetics , Sulfaguanidine/pharmacology , Sulfhydryl Compounds/metabolism
5.
Biochem Biophys Res Commun ; 495(1): 174-178, 2018 01 01.
Article in English | MEDLINE | ID: mdl-29101028

ABSTRACT

Mycobacterium tuberculosis (M.tb.), the causative agent of tuberculosis (TB), cannot synthesize GSH, but synthesizes two major low molecular weight thiols namely mycothiol (MSH) and ergothioneine (ERG). Gamma-glutamylcysteine (GGC), an intermediate in GSH synthesis, has been implicated in the protection of lactic acid bacteria from oxidative stress in the absence of GSH. In mycobacteria, GGC is an intermediate in ERG biosynthesis, and its formation is catalysed by EgtA (GshA). GGC is subsequently used by EgtB in the formation of hercynine-sulphoxide-GGC. In this study, M.tb. mutants harbouring unmarked, in-frame deletions in each of the fives genes involved in ERG biosynthesis (egtA, egtB, egtC, egtD and egtE) or a marked deletion of the mshA gene (required for MSH biosynthesis) were generated. Liquid chromatography tandem mass spectrometry analyses (LC-MS) revealed that the production of GGC was elevated in the MSH-deficient and the ERG-deficient mutants. The ERG-deficient ΔegtB mutant which accumulated GGC was more resistant to oxidative and nitrosative stress than the ERG-deficient, GGC-deficient ΔegtA mutant. This implicates GGC in the detoxification of reactive oxygen and nitrogen species in M.tb.


Subject(s)
Dipeptides/metabolism , Ergothioneine/genetics , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , Nitrosative Stress , Oxidative Stress , Biosynthetic Pathways , Cysteine/genetics , Cysteine/metabolism , Dipeptides/genetics , Ergothioneine/metabolism , Gene Deletion , Glycopeptides/genetics , Glycopeptides/metabolism , Humans , Inositol/genetics , Inositol/metabolism , Tuberculosis/microbiology
6.
Int J Food Microbiol ; 217: 170-6, 2016 Jan 18.
Article in English | MEDLINE | ID: mdl-26544204

ABSTRACT

Mycobacterium bovis that causes Bovine tuberculosis (BTB) can be transmitted to humans thought consumption of raw and raw fermented milk products from diseased animals. Lactic acid bacteria (LAB) used in popular traditional milk products in Africa produce anti-microbial compounds that inhibit some pathogenic and spoilage bacteria. M. bovis BCG is an attenuated non-pathogenic vaccine strain of M. bovis and the aim of the study was to determine the effect of the fermentation process on the survival of M. bovis BCG in milk. M. bovis BCG at concentrations of 6 log CFU/ml was added to products of kefir fermentation. The survival of M. bovis BCG was monitored at 12-h intervals for 72 h by enumerating viable cells on Middlebrook 7H10 agar plates enriched with 2% BD BACTEC PANTA™. M. bovis BCG was increasingly reduced in sterile kefir that was fermented for a period of 24h and longer. In the milk fermented with kefir grains, Lactobacillus paracasei subsp. paracasei or Lactobacillus casei, the viability of M. bovis BCG was reduced by 0.4 logs after 24h and by 2 logs after 48 h of fermentation. No viable M. bovis BCG was detected after 60 h of fermentation. Results from this study show that long term fermentation under certain conditions may have the potential to inactivate M. bovis BCG present in the milk. However, to ensure safety of fermented milk in Africa, fermentation should be combined with other hurdle technologies such as boiling and milk pasteurisation.


Subject(s)
Cultured Milk Products/microbiology , Fermentation/physiology , Food Contamination , Lactobacillaceae/metabolism , Mycobacterium bovis/growth & development , Africa , Animals , Antibiosis , Cattle , Humans , Lactic Acid/metabolism
7.
Benef Microbes ; 5(3): 351-66, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24463204

ABSTRACT

Many lactic acid bacteria produce bacteriocins with a rather broad spectrum of inhibition, which could offer potential applications in food preservation. Bacteriocin production by starter cultures may bring advantage to these strains in competitive interactions with pathogenic bacteria from the food matrix. The objective of this study was to determine the safety of beneficial strains (Lactobacillus plantarum ST202Ch and ST216Ch, Enterococcus faecium ST211Ch, and Lactobacillus sakei ST22Ch, ST153Ch and ST154Ch) previously isolated from fermented meat products and characterised as bacteriocin producers. Auto-aggregation was strain-specific, and values of 28.97, 27.86 and 28.56% were recorded for L. sakei ST22Ch, ST153Ch and ST154Ch, respectively, 16.95 and 14.58% for L. plantarum ST202Ch and ST216Ch, respectively, and 12.77% for E. faecium ST211Ch. Various degrees of co-aggregation between 28.85 and 44.76% for Listeria monocytogenes 211 and 409, and between 23.60 to 34.96% for E. faecium ATCC 19443 were observed. According to the results of the diffusion method, the studied strains demonstrated susceptibility to penicillin G, ampicillin, amoxicillin, amoxicillin/clavulonic acid, imipenem, linezolid, and tetracycline. In addition, the susceptibility of the six strains to various non-antibiotic commercial drugs was examined. Production of ß-galactosidase by L. sakei ST22Ch, ST153Ch and ST154Ch, L. plantarum ST202Ch and ST216Ch, and E. faecium ST211Ch was confirmed by employing sterile filter paper discs impregnated with o-nitrophenyl-ß-D-galactopyranose. A statistically significant (P<0.001) inhibition of Mycobacterium tuberculosis growth by bacteriocins produced by L. plantarum ST202Ch (38.3%) and ST216Ch (48.6%), L. sakei ST153Ch (16.2%) and ST154Ch (16.1%), and E. faecium ST211Ch (21.7%) was observed. As determined by the polymerase chain reaction, the tested strains showed a low virulence gene profile.


Subject(s)
Bacteriocins/pharmacology , Lactobacillus/classification , Meat Products/microbiology , Mycobacterium tuberculosis/growth & development , Probiotics/pharmacology , Anti-Bacterial Agents , Bacteriocins/biosynthesis , Bioreactors , Drug Resistance, Bacterial , Enterococcus faecium/drug effects , Fermentation/physiology , Food Microbiology , Lactobacillus/isolation & purification , Lactobacillus/pathogenicity , Lactobacillus plantarum/drug effects , Listeria monocytogenes/drug effects , Microbial Sensitivity Tests , Mycobacterium tuberculosis/drug effects , Portugal , Probiotics/adverse effects , beta-Galactosidase/metabolism
8.
J Clin Microbiol ; 35(6): 1545-9, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9163479

ABSTRACT

Analysis of restriction fragment length polymorphisms in the genome of Mycobacterium tuberculosis (DNA fingerprinting) has proved to be a useful epidemiological tool in the study of tuberculosis within populations or communities. However, to date, no similar method has been developed to study the epidemiology of nontuberculous mycobacteria (NTM). In this communication, we report that a simple oligonucleotide repeat, (GTG)5, can be used to accurately genotype all species and strains of NTM tested. We suggest that this technology is an easily applied and accurate tool which can be used for the study of the epidemiology of NTM.


Subject(s)
DNA Fingerprinting/methods , Mycobacterium/genetics , Oligodeoxyribonucleotides , Polymorphism, Restriction Fragment Length , DNA, Bacterial/analysis , Deoxyribonucleases, Type II Site-Specific , Humans , Mycobacterium/classification , Mycobacterium Infections/epidemiology , Mycobacterium Infections/microbiology , Reproducibility of Results
9.
Br J Cancer ; 70(2): 195-8, 1994 Aug.
Article in English | MEDLINE | ID: mdl-8054265

ABSTRACT

The establishment of a new prostate cell line (BM1604) from a human prostatic adenocarcinoma is reported. The line was rapidly established by culture of tissue on an extracellular matrix, previously laid down by culture of non-related cells. The method has been shown to work well, and other prostate lines have recently been cultured in this way. The cells have a doubling time of 28 h. DNA fingerprinting comparison of the genome from the tumour, the germline and the cells shows that somatic mutations have occurred in the tumour and that clonal selection has clearly occurred in establishment of the line. Many somatic mutations are apparent in the selected cells, which are now stable in culture. This method and the cells may be a useful addition to the limited material available for the in vitro study of prostate cells.


Subject(s)
Adenocarcinoma/genetics , Adenocarcinoma/pathology , DNA Fingerprinting , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Tumor Cells, Cultured , Aged , DNA/analysis , DNA, Neoplasm/analysis , Humans , Immunohistochemistry , Leukocytes/chemistry , Male
10.
J Clin Microbiol ; 32(5): 1318-21, 1994 May.
Article in English | MEDLINE | ID: mdl-7914207

ABSTRACT

Culture of Mycobacterium tuberculosis provides no information on the identity of a strain or the distribution of such a strain in the community. Strain identification of M. tuberculosis can help to address important epidemiological questions, e.g., the origin of an infection in a patient's household or community, whether reactivation of infection is endogenous or exogenous in origin, and the spread and early detection of organisms with acquired antibiotic resistance. To research this problem, strain identification must be reliable and accurate. Although genetic identification techniques already exist, it is valuable to have genetic identification techniques based on a number of genetic markers to improve the accurate identification of M. tuberculosis strains. We show that oligonucleotide (GTG)5 can be successfully applied to the identification of M. tuberculosis strains. This technique may be particularly useful in cases in which M. tuberculosis strains have few or no insertion elements (e.g., IS6110) or in identifying other strains of mycobacteria when informative probes are lacking.


Subject(s)
DNA Probes/genetics , DNA, Bacterial/genetics , Mycobacterium tuberculosis/genetics , Repetitive Sequences, Nucleic Acid , Adult , Bacterial Typing Techniques , Base Sequence , Child , DNA Fingerprinting , DNA Transposable Elements , Evaluation Studies as Topic , Female , Genetic Markers , Humans , Male , Middle Aged , Molecular Sequence Data , Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/isolation & purification , Polymorphism, Restriction Fragment Length , South Africa/epidemiology , Species Specificity , Tuberculosis, Pulmonary/epidemiology , Tuberculosis, Pulmonary/microbiology
12.
Anticancer Res ; 10(3): 833-6, 1990.
Article in English | MEDLINE | ID: mdl-2369096

ABSTRACT

One hundred and seventy-eight patients at risk for gastric carcinoma had upper gastrointestinal endoscopy. Twenty-seven selected patients with the type B of chronic atrophic gastritis, 32 patients with normal mucosa and 47 non-scoped healthy controls were tested for plasma vitamin C, retinol and tocopherol. The total vitamin C level was also assessed in gastric juice of scoped patients. Micronutrient levels were related to gastric pH, nitrites and gastric mucosal pathology. The study showed a higher level of pH (greater than 4) and high nitrites in gastric juice in patients with chronic atrophic gastritis, gastric malignant and dysplastic lesions. Neither the hypochlorhydria nor gastric nitrites affected the prevalence of C. pylori in gastric mucosa. Low gastric and plasma concentrations of vitamin C observed in patients with chronic atrophic gastritis showed an inverted relationship with pH level, and an inter-relationship of other vitamins with antioxidant properties (vitamins A and E).


Subject(s)
Gastric Juice/analysis , Gastritis, Atrophic/physiopathology , Gastritis/physiopathology , Nitrites/analysis , Stomach Neoplasms/etiology , Vitamins/analysis , Ascorbic Acid/analysis , Ascorbic Acid/blood , Endoscopy , Female , Gastric Acidity Determination , Gastric Mucosa/pathology , Gastritis, Atrophic/pathology , Humans , Male , Middle Aged , Risk Factors , Stomach Neoplasms/diagnosis , Stomach Neoplasms/pathology , Stomach Ulcer/pathology , Stomach Ulcer/physiopathology , Vitamin A/blood , Vitamin E/blood
13.
Cancer Res ; 48(20): 5660-2, 1988 Oct 15.
Article in English | MEDLINE | ID: mdl-3167823

ABSTRACT

DNA "fingerprint" analysis has recently become known as a valuable technique for positive identification of any given individual. The chances for mistaken identity have been estimated to be 10(-6) for close siblings or as little as 10(-23) for randomly selected individuals. This methodology thus represents a significant improvement over previously established identification tests using protein or enzyme analysis techniques and has already found application in forensic medicine. One of the chief problems in tissue culture studies is the question of the unequivocal identity of the cultured cells used and the very real possibility of their being contaminated by cells of a similar morphological appearance. We report here the application of the DNA "fingerprint" technique to the genotypic analysis of cultured human squamous carcinoma cells. The results show that a number of lines, designation HCu, have become cross-contaminated. Lines SNO, HCu 10, and HCu 13 are genetically distinct, however lines HCu 10, 18, 33, 37, and 39 are genetically identical and are in fact subcultures of the same cells. In addition, a myocardial line known as Girardi is shown to be identical to HeLa cells. The introduction of this technique to tissue culture laboratories could therefore prevent contaminated cultures from being disseminated or used in research studies.


Subject(s)
Carcinoma, Squamous Cell/genetics , DNA, Neoplasm/analysis , Esophageal Neoplasms/genetics , Nucleotide Mapping , Cell Line , HeLa Cells/analysis , Humans
14.
Mol Cell Biochem ; 79(1): 57-62, 1988 Jan.
Article in English | MEDLINE | ID: mdl-2453787

ABSTRACT

Differentiation of mononucleated myoblasts to multinucleated myotubes is accompanied by hypertrophy achieved by co-ordinated synthesis of muscle proteins. This process may be achieved by co-ordinated synthesis and translation of new mRNA or gradual accumulation of constitutively synthesized mRNA, followed by coordinated translational activation. If the former process occurs, many structural alterations should occur in chromatin, whereas in the latter scenario, no chromatin changes will be necessary. The results of our investigation into chromatin structure of myoblast and myotube nuclei show that according to techniques used, viz. chromatin solubilization by nucleases, thermal denaturation, in vitro transcription, nucleosome sizing, there are major structural changes in chromatin during muscle cell differentiation. Since these alterations were detectable at a fairly gross level, many genes must be affected which could account for the increase in RNA and proteins observed in myotubes. This evidence argus in favour of new mRNA synthesis for rapid translation, rather than a gradual accumulation of mRNA followed by co-ordinated translation.


Subject(s)
Chromatin/analysis , Muscle Development , Muscle Proteins/biosynthesis , Animals , Cell Differentiation , Chickens , DNA/analysis , Deoxyribonuclease I/pharmacology , Electrophoresis, Agar Gel , Micrococcal Nuclease/pharmacology , Muscles/cytology , Nucleic Acid Denaturation , Nucleosomes , RNA/analysis , Transcription, Genetic
15.
Nucleic Acids Res ; 12(6): 2717-29, 1984 Mar 26.
Article in English | MEDLINE | ID: mdl-6200834

ABSTRACT

One of the changes accompanying skeletal muscle cell (myoblast) fusion is a dramatic increase in synthesis of muscle specific proteins, one of which is myosin. The underlying mechanism for this burst in synthesis is not yet understood but may occur by two mechanisms: (a) gradual storage of mRNA and translational control as found by others or (b) gene activation and rapid synthesis of mRNA for immediate translation. In this paper we show that the myosin gene changes its organization such that postfusion skeletal muscle cells show an increased susceptibility to DNase I, a recognized probe for gene activation. We also show that this change accompanies an increase in rate of transcription and an increased cell content of myosin heavy chain mRNA. This work shows that transcriptional control is an important mechanism during muscle cell development in addition to the translational control shown by other workers.


Subject(s)
Genes , Muscles/embryology , Myosins/genetics , Transcription, Genetic , Animals , Cell Differentiation , Cell Nucleus/metabolism , Chick Embryo , Chickens , DNA/metabolism , DNA Restriction Enzymes , Muscles/metabolism , Nucleic Acid Hybridization , Poly A/genetics , RNA/genetics , RNA, Messenger
SELECTION OF CITATIONS
SEARCH DETAIL
...